Today: 4 February 2026
Subscribe
Browse Category

Analyst Forecasts News 15 December 2025

Bank of America (BAC) Stock Today: Latest News, Analyst Forecasts, and Key Catalysts for 2026 (Dec. 15, 2025)

Bank of America (BAC) Stock Today: Latest News, Analyst Forecasts, and Key Catalysts for 2026 (Dec. 15, 2025)

Bank of America Corporation (NYSE: BAC) stock is in focus on Monday, December 15, 2025, as investors weigh two big cross-currents: a shifting U.S. rate outlook after the Federal Reserve’s December cut, and fresh momentum behind the “banks-as-AI-efficiency-winners” narrative that has been gaining traction across global financials. As of 15:40 UTC on Dec. 15, BAC shares were trading around $55.54,…
15 December 2025
····
Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

December 15, 2025 — Immunome, Inc. (NASDAQ: IMNM) is having the kind of biotech day that traders circle in red ink: a major clinical trial win, a sharp move in the share price, and a fast-rising debate over what “best-in-class” might be worth if regulators agree. The catalyst is Immunome’s positive topline Phase 3 RINGSIDE results for varegacestat (formerly AL102)…
15 December 2025
·····
Palantir Stock (PLTR) Rises on French DGSI Contract Renewal: Today’s News, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Palantir Stock (PLTR) Rises on French DGSI Contract Renewal: Today’s News, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Palantir Technologies Inc. (PLTR) is starting the week back in the spotlight after the company announced a three-year renewal with France’s domestic intelligence agency (DGSI)—a headline that reinforces Palantir’s deepening ties to government and defense customers in the U.S. and Europe. Business Wire As of midday Monday, Palantir shares were trading around $186.60, up roughly 1.7% on the session, with…
15 December 2025
·····
Amazon Stock Today (AMZN): Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 15, 2025

Amazon Stock Today (AMZN): Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 15, 2025

Dec. 15, 2025 — Amazon.com, Inc. (NASDAQ: AMZN) stock is starting the week in the spotlight as investors weigh a fresh mix of catalysts: expanding AI commitments at Amazon Web Services (AWS), aggressive international investment plans, new retail logistics experiments, and a steady drumbeat of regulatory headlines. In early U.S. trading on Monday, Amazon shares were around $225 (down modestly…
15 December 2025
·····
Ondas Holdings (ONDS) Stock: Latest News, Debt Exchange Update, and Analyst Forecasts for December 15, 2025

Ondas Holdings (ONDS) Stock: Latest News, Debt Exchange Update, and Analyst Forecasts for December 15, 2025

Ondas Holdings Inc. (NASDAQ: ONDS) is starting the week in focus as investors weigh a fast-moving mix of defense-drone catalysts, rail communications strategy, and a fresh SEC filing outlining a proposed exchange of subsidiary-level notes and warrants—a move that could simplify ownership of Ondas Autonomous Systems (OAS) but also introduce dilution and a sizable one-time accounting charge. SEC As of…
15 December 2025
···
Intel Stock (INTC) Today: Latest News, Analyst Forecasts, and What Could Move Shares Next (Dec. 15, 2025)

Intel Stock (INTC) Today: Latest News, Analyst Forecasts, and What Could Move Shares Next (Dec. 15, 2025)

Dec. 15, 2025 — Intel Corporation stock is starting the week with investors weighing a familiar Intel cocktail: big strategic ambition, real execution progress, and headline risk that can yank sentiment around faster than a wafer in a vacuum chamber. Intel shares last closed at $37.81 on Friday (Dec. 12), down 4.3% on the day and sitting about 14% below…
15 December 2025
·····
Pfizer Stock (PFE) News Today: Dividend, 2026 Guidance Call, Obesity Deals, and Analyst Forecasts (Dec. 15, 2025)

Pfizer Stock (PFE) News Today: Dividend, 2026 Guidance Call, Obesity Deals, and Analyst Forecasts (Dec. 15, 2025)

Pfizer Inc. (NYSE: PFE) enters the new week with its stock hovering around $25.85 in early Monday trading, as investors weigh a familiar late-2025 mix: a high dividend, a rebuilding growth story after the COVID boom, and a pipeline/M&A strategy designed to refill the revenue engine ahead of major patent cliffs. The immediate spotlight is tomorrow morning’s full-year 2026 guidance…
15 December 2025
·····
SoFi Technologies (SOFI) Stock Today: Latest News, Analyst Forecasts, and 2026 Catalysts (Dec. 15, 2025)

SoFi Technologies (SOFI) Stock Today: Latest News, Analyst Forecasts, and 2026 Catalysts (Dec. 15, 2025)

SoFi Technologies, Inc. (NASDAQ: SOFI) is starting the week in a “cooldown phase” after one of the most headline-heavy stretches of its 2025 rally: a $1.5 billion equity raise, fresh analyst target changes, new product launches, and an ambitious roadmap in crypto, blockchain payments, and a potential SoFi-branded stablecoin. As of the latest available trade timestamp on December 15, 2025,…
15 December 2025
·····
BigBear.ai (BBAI) Stock News Today: Share Authorization Vote, Ask Sage Deal, and Analyst Forecasts as of Dec. 15, 2025

BigBear.ai (BBAI) Stock News Today: Share Authorization Vote, Ask Sage Deal, and Analyst Forecasts as of Dec. 15, 2025

BigBear.ai Holdings, Inc. (NYSE: BBAI) is heading into mid-December with traders focused on one big theme: the company is trying to “reload the toolbox” for growth—via a pending acquisition, international expansion, and a shareholder vote that could materially change its capital structure. As of Friday’s close (Dec. 12, 2025), BBAI finished around $6.38, and early pre-market Monday (Dec. 15, 2025)…
15 December 2025
·····
Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi stock is under pressure on December 15, 2025, after the French drugmaker disclosed two setbacks tied to its experimental multiple sclerosis (MS) medicine tolebrutinib—a regulatory delay in the U.S. for one progressive MS form and a failed Phase 3 endpoint in another. The update pushed Sanofi shares down about 4% in Paris trading, as investors recalibrated expectations for one…
15 December 2025
·····
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc. (NYSE: CLS; TSX: CLS) is back in the spotlight on December 15, 2025 after a sharp pullback that reminded investors of an uncomfortable truth: even “AI infrastructure winners” can get whipsawed when the market mood flips. On the NYSE, Celestica closed at $306.50 on December 12, down $44.91 (-12.78%), and was indicated higher in early pre-market trading on…
15 December 2025
······
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping Services Ltd. stock is back in the spotlight on Dec. 15, 2025, caught at the intersection of three forces that can yank any shipping name around: freight-rate expectations, corporate control drama, and the always-contentious question of how much cash a cyclical carrier should return to shareholders. As of the latest available trading update, ZIM shares were around…
15 December 2025
······
1 … 27 28 29 30 31 … 43

Stock Market Today

  • Equinor to Start $375 Million First Tranche of 2026 Share Buy-Back Program
    February 4, 2026, 1:21 AM EST. Equinor ASA will begin the first tranche of its 2026 share buy-back programme on February 5, targeting up to USD 375 million. The tranche includes USD 123.75 million worth of shares purchased from the market, with the remainder redeemed from the Norwegian State, which holds a 67% ownership stake. The buy-back aims to reduce issued share capital by cancelling repurchased shares at the May 2026 annual general meeting. The full 2026 plan totals up to USD 1.5 billion, structured in tranches and subject to market conditions and board approval. The company set share price parameters between NOK 50 and NOK 1,000, with a maximum of 84 million shares authorized for repurchase. The programme reflects Equinor's disciplined capital management following its Q4 earnings announcement.
Go toTop